Document is current
Any future updates will be listed below
-
Authors
Shipton, Michael J. https://orcid.org/0000-0002-3031-5447
Kinsella, Paul M.
Davis, Thomas https://orcid.org/0000-0002-1576-7998
Azzato, Francesca
Taiaroa, George
Szer, Jeff https://orcid.org/0000-0001-6783-2301
Routledge, David
Smibert, Olivia
- License Information
-
More Information
Article History
Received: 20 March 2022
Revised: 27 March 2022
Accepted: 30 March 2022
First Online: 11 April 2022
Competing interests
: JS has received funding for consulting fees from Takeda and Alexion; has received honoraria from Takeda, Alexion and Pfizer; and is on an advisory board for Prevail Therapeutics and Novartis. DR has received honoraria from Amgen, BMS, Pfizer, Janssen and Sandoz; and financial support for attending meetings from Amgen and BMS. All others authors report no conflicts of interest. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest.
: The patient’s next of kin provided informed consent for the publication of this case presentation.
